Recently published efficacy and safety data are reviewed and the potential role of this novel GLP-1 receptor agonist in patient care is discussed
JAMA Intern Med 2024;184:1301-12.ArticlePubMedPMC 78
Current prescribing information emphasizes individual tolerability and symptom monitoring rather than a fixed week-by-week pattern
Like GLP-1, GIP helps regulate insulin and blood sugar levels, but it also appears to influence how the body uses and stores energy
References Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP (2017) The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Both of those are brand-name semaglutide manufactured at scale by Novo Nordisk